ArticleOncotarget2017

Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms.

Tri Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.